Ginkgo Bioworks Holdings, Inc.

DNA

$9.35

Name : Ginkgo Bioworks Holdings, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $566,518,592.00

EPSttm : -6.18

Ginkgo Bioworks Holdings, Inc.

$9.35

1.30%

$0.12

Float Short %

15.73

Margin Of Safety %

Put/Call OI Ratio

0.24

EPS Next Q Diff

0.32

EPS Last/This Y

4.89

EPS This/Next Y

2.01

Price

9.38

Target Price

10.5

Analyst Recom

3.33

Performance Q

6.61

Relative Volume

0.8

Beta

1.56

Ticker: DNA

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-13	DNA	9.6	0.08	0.21	99767
2026-01-14	DNA	9.84	0.08	0.72	99918
2026-01-15	DNA	9.58	0.08	0.29	100142
2026-01-16	DNA	9.56	0.08	0.46	100635
2026-01-20	DNA	9.01	0.36	0.66	11153
2026-01-21	DNA	9.79	0.38	0.11	11390
2026-01-22	DNA	10.7	0.37	0.15	11703
2026-01-23	DNA	10.02	0.34	0.14	12241
2026-01-26	DNA	9.85	0.34	0.05	12390
2026-01-27	DNA	9.72	0.32	0.29	13177
2026-01-28	DNA	9.45	0.32	0.15	13309
2026-01-29	DNA	9.31	0.32	0.07	13389
2026-01-30	DNA	8.98	0.32	0.03	13396
2026-02-02	DNA	9.17	0.32	0.20	13397
2026-02-03	DNA	8.8	0.32	0.01	13909
2026-02-04	DNA	8.27	0.36	0.15	12723
2026-02-05	DNA	8.35	0.35	0.02	12792
2026-02-06	DNA	10.11	0.26	0.06	16174
2026-02-09	DNA	10.21	0.23	0.02	18266
2026-02-10	DNA	9.23	0.22	0.01	18970
2026-02-11	DNA	9.36	0.24	0.01	17580
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-13	DNA	9.60	8.5	-	-5.64
2026-01-14	DNA	9.85	8.5	-	-5.64
2026-01-15	DNA	9.57	8.5	-	-5.64
2026-01-16	DNA	9.56	8.5	-	-5.64
2026-01-20	DNA	9.04	8.5	-	-5.64
2026-01-21	DNA	9.80	8.5	-	-5.64
2026-01-22	DNA	10.71	8.5	-	-5.64
2026-01-23	DNA	10.02	8.5	-	-5.64
2026-01-26	DNA	9.85	8.5	-	-5.64
2026-01-27	DNA	9.71	8.5	-	-5.64
2026-01-28	DNA	9.42	8.5	-	-5.64
2026-01-29	DNA	9.31	8.5	-	-5.64
2026-01-30	DNA	8.99	8.5	-	-5.64
2026-02-02	DNA	9.17	8.5	-	-5.64
2026-02-03	DNA	8.80	8.5	-	-5.64
2026-02-04	DNA	8.27	8.5	-	-5.64
2026-02-05	DNA	8.35	8.5	-	-5.64
2026-02-06	DNA	10.11	8.5	-	-5.64
2026-02-09	DNA	10.14	8.5	-	-5.64
2026-02-10	DNA	9.23	8.5	-	-5.64
2026-02-11	DNA	9.38	8.5	-	-5.64
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-13	DNA	-0.18	-7.59	15.68
2026-01-14	DNA	-0.18	-7.59	15.68
2026-01-15	DNA	-0.18	-7.59	15.68
2026-01-16	DNA	-0.18	-7.59	15.68
2026-01-20	DNA	-0.18	-6.92	15.68
2026-01-21	DNA	-0.18	-6.92	15.68
2026-01-22	DNA	-0.18	-6.92	15.68
2026-01-23	DNA	-0.18	-6.92	15.68
2026-01-26	DNA	-0.18	-6.68	15.68
2026-01-27	DNA	-0.18	-6.68	15.68
2026-01-28	DNA	-0.18	-6.68	16.51
2026-01-29	DNA	-0.18	-6.68	16.51
2026-01-30	DNA	-0.18	-6.68	16.51
2026-02-02	DNA	-0.18	-8.40	16.51
2026-02-03	DNA	-0.18	-8.40	16.51
2026-02-04	DNA	-0.18	-8.40	16.51
2026-02-05	DNA	-0.18	-8.40	16.51
2026-02-06	DNA	-0.18	-8.40	16.51
2026-02-09	DNA	-0.18	-7.15	16.51
2026-02-10	DNA	-0.18	-7.15	16.51
2026-02-11	DNA	-0.18	-7.15	15.73
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-1.45

Avg. EPS Est. Current Quarter

-1.8

Avg. EPS Est. Next Quarter

-1.13

Insider Transactions

-0.18

Institutional Transactions

-7.15

Beta

1.56

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.5

Max Drawdown 5-Year %

Target Price

10.5

P/E

Forward P/E

PEG

P/S

3.14

P/B

0.9

P/Free Cash Flow

EPS

-6.23

Average EPS Est. Cur. Y

-5.64

EPS Next Y. (Est.)

-3.63

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-188

Relative Volume

0.8

Return on Equity vs Sector %

-88.5

Return on Equity vs Industry %

-72.1

EPS 1 7Days Diff

-0.4

EPS 1 30Days Diff

-0.39

EBIT Estimation

Ginkgo Bioworks Holdings, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 834

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

stock quote shares DNA – Ginkgo Bioworks Holdings, Inc. Stock Price stock today

news today DNA – Ginkgo Bioworks Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DNA – Ginkgo Bioworks Holdings, Inc. yahoo finance google finance

stock history DNA – Ginkgo Bioworks Holdings, Inc. invest stock market

stock prices DNA premarket after hours

ticker DNA fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: DNA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y